There are limited and conflicting reports on the prognostic utility of PIK3CA and the assessment of PIK3CA in cervical cancer before radical hysterectomy may help identify patients at higher risk of node-positive disease (53). This evidence concerns the gene PIK3CA and cervical carcinoma.